CIK 0001628171
- Large accelerated filer
Revolution Medicines, Inc.
Sign in to watch- Ticker
- RVMD
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 472029180
- Phone
- +1 650-481-6801
- Business address
- 700 SAGINAW DR, REDWOOD CITY, CA, 94063
Securities
- RVMD Common Stock Nasdaq
- RVMDW Warrant Nasdaq
- 4 Exercise or conversion GOLDSMITH MARK A acquired 30,846 shares (option exercise)
- 4 Planned sale Chief Operating Officer sold 4,329 shares at $45.40 ($196,553)
- 4 Planned sale GOLDSMITH MARK A sold 11,714 shares at $45.40 ($531,860)
- 4 Planned sale Kelsey Stephen Michael sold 4,663 shares at $45.40 ($211,718)
- 4 Planned sale General Counsel sold 1,599 shares at $45.40 ($72,601)
- 4 Planned sale Chief Financial Officer sold 2,635 shares at $45.40 ($119,639)
- 4 Open-market buy Director bought 1,304,347 shares at $46.00 ($59,999,962)
- 4 Planned sale General Counsel sold 2,554 shares at $55.13 ($140,811)
- 4 Planned sale Kelsey Stephen Michael sold 16,666 shares at an average $58.65 ($977,509)
- 4 Planned sale General Counsel sold 6,000 shares at $60.00 ($360,000)
- 4 Planned sale GOLDSMITH MARK A sold 70,000 shares at an average $55.41 ($3,878,773)
- 4 Planned sale Director sold 5,000 shares at $54.14 ($270,715)
- 4 Planned sale Kelsey Stephen Michael sold 16,666 shares at an average $49.49 ($824,804)
- 4 Planned sale Chief Operating Officer sold 50,000 shares at $50.34 ($2,517,055)
- 4 Planned sale GOLDSMITH MARK A sold 30,000 shares at $50.36 ($1,510,773)
- 4 Planned sale Chief Financial Officer sold 10,000 shares at $50.30 ($502,979)
- 4 Planned sale General Counsel sold 6,000 shares at $50.17 ($301,027)
- 4 Planned sale Director sold 5,200 shares at $48.02 ($249,716)
- 4 Planned sale GOLDSMITH MARK A sold 10,000 shares at an average $44.93 ($449,322)
- 4 Planned sale Chief Financial Officer sold 2,244 shares at $44.19 ($99,152)
Page 7 of 21 · 414 filings